Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Cancer Research

• Publication date

  2006-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-0417PMID 16914574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The changing face of prostate cancer.

  2005cited by this paper
• Cancer of the prostate.

  2005cited by this paper
• Molecular markers and prostate cancer prognosis.

  2004cited by this paper
• Cancer of the prostate

  2003cited by this paper
• Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

  2003cited by this paper
• Caveolin‐1 expression is a predictor of recurrence‐free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients

  2003cited by this paper
• Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

  2001cited by this paper
• Elevated caveolin-1 levels in African-American versus white-American prostate cancer.

  2000cited by this paper
• Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments.

  2000cited by this paper
• Caveolins and Cellular Cholesterol Balance

  2000cited by this paper
• Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

  1999cited by this paper
• Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.

  1999cited by this paper
• Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

  1998cited by this paper
• Role of plasmalemmal caveolae in signal transduction.

  1998cited by this paper

• Caveolin-1 in prostate Cancer: Novel insights and therapeutic opportunities-A review.

  2025cites this paper
• Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights

  2025cites this paper
• Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions

  2024cites this paper
• Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer

  2023cites this paper
• Expression of caveolin family proteins in serum of patients with systemic lupus erythematosus

  2021cites this paper
• Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research

  2021cites this paper
• Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis

  2021cites this paper
• The Biomarker Potential of Caveolin-1 in Penile Cancer

  2021cites this paper
• Caveola-forming proteins and prostate cancer

  2020cites this paper
• Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

  2020cites this paper
• An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells

  2020cites this paper
• An inverted Caveolin-1 topology defines a novel exosome secreted from prostate cancer cells

  2020cites this paper
• The paracrine induction of prostate cancer progression by caveolin-1

  2019cites this paper
• Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma

  2019cites this paper
• Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.

  2018cites this paper
• Caveolin‐1, cancer and therapy resistance

  2018cites this paper
• Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

  2018cites this paper
• Caveolin-1: a mediator of Glioblastoma cell invasion and an independent negative biomarker of Glioblastoma patient survival

  2018influential citation
• Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned

  2018cites this paper
• Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer

  2017cites this paper
• Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy.

  2017cites this paper
• Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?

  2017cites this paper
• Prognostic role of epithelial caveolin-1 in cancer : a meta-analysis

  2016influential citation
• Prognostic value of Caveolin‐1 in patients treated with radical prostatectomy: a multicentric validation study

  2016cites this paper
• Pigment epithelium-derived factor inhibits caveolin-induced interleukin-8 gene expression and proliferation of human prostate cancer cells.

  2015cites this paper
• Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.

  2015cites this paper
• Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis

  2015cites this paper
• Caveolin-1 as a biomarker to predict therapeutic effect of low-frequency ultrasound combined with SonoVue on prostate cancer in nude mice model

  2014cites this paper
• Prostate cancer: the significance of the cAMP signalling pathway

  2014cites this paper
• Caveola-forming proteins caveolin-1 and PTRF in prostate cancer

  2013cites this paper
• Secreted caveolin-1 enhances periodontal inflammation by targeting gingival fibroblasts.

  2013cites this paper
• Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models

  2013cites this paper
• Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

  2013cites this paper
• PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer

  2013cites this paper
• PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis

  2013cites this paper
• Cancer Genes and Genomics Caveolin-1 Upregulation Contributes to c-Myc – Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

  2012cites this paper
• Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall

  2012cites this paper
• Anti-caveolin-1 Antibodies As Anti-Prostate Cancer Therapeutics

  2012cites this paper
• Caveolin-1 and prostate cancer progression.

  2012cites this paper
• Local and Distant Effects of Caveolin-1 on Prostate Cancer Progression

  2012cites this paper
• Bronchiolitis obliterans syndrome after lung transplantation: biomarkers for inflammation and fibrogenesis

  2012cites this paper
• Changes in the location of oxytocin receptor in the human prostate

  2012cites this paper
• The Role of Caveolin-1 in Skin Cancer

  2012cites this paper
• Title Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall Permalink

  2012cites this paper
• PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9.

  2011cites this paper
• A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation

  2011cites this paper
• Caveolin-1 as a potential high-risk prostate cancer biomarker.

  2011cites this paper
• Caveolin-1 Upregulation Contributes to c-Myc–Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

  2011cites this paper
• Caveolin 1 protein expression in renal cell carcinoma predicts survival

  2011cites this paper
• Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.

  2011cites this paper
• The role of caveolin-1 in prostate cancer: clinical implications

  2010cites this paper
• Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit

  2010cites this paper
• Association of caveolin‐1 and ‐2 genetic variants and post‐treatment serum caveolin‐1 with prostate cancer risk and outcomes

  2010cites this paper
• The senescence pathway in prostatic carcinogenesis

  2010cites this paper
• Caveolin-1 Promotes Autoregulatory, Akt-Mediated Induction of Cancer-Promoting Growth Factors in Prostate Cancer Cells

  2009cites this paper
• The biology of caveolae: achievements and perspectives.

  2009cites this paper
• Expression of caveolin-1 in penile cavernosal tissue in a denervated animal model after treatment with sildenafil citrate.

  2009cites this paper
• Caveolin‐1 tumor‐promoting role in human melanoma

  2009cites this paper
• CAVEOLIN-1 MEDIATED P53 ACTIVATION IN STRESS INDUCED PREMATURE SENESCENCE AND ITS ANTAGONISTIC PLEIOTROPIC IMPLICATIONS IN CANCER

  2009cites this paper
• Neue Biomarker und Anwendung multivariater Modelle zur Detektion des Prostatakarzinoms

  2009cites this paper
• Functional Analysis of Secreted Caveolin-1 in Mouse Models of Prostate Cancer Progression

  2009cites this paper
• New markers and multivariate models for prostate cancer detection.

  2009cites this paper
• An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation

  2009cites this paper
• Chapter 4 The Biology of Caveolae

  2009cites this paper
• Caveolin-1: A tumor-promoting role in human cancer

  2008cites this paper
• Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase

  2008cites this paper
• Signal transducer and activator of transcription 5 A / B in prostate and breast cancers

  2008cites this paper
• Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.

  2008cites this paper
• Clinical implications of caveolins in malignancy and their potential as therapeutic targets

  2008cites this paper
• Caveats of caveolin-1 in cancer progression.

  2008cites this paper
• Beyond prostate-specific antigen: alternate serum markers

  2008cites this paper
• Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

  2008cites this paper
• Caveolin‐1 overexpression is associated with aggressive prostate cancer recurrence

  2007cites this paper
• Role of Caveolin-1 in Prostate Cancer Angiogenesis

  2007cites this paper
• Cancer Management and Research

  year unknowncites this paper